日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

更正:卡博替尼在接受常规治疗的转移性肾细胞癌患者中的暴露-反应关系

Blanchet, Benoit; Xu-Vuillard, Alexandre; Jouinot, Anne; Puisset, Florent; Combarel, David; Huillard, Olivier; Le Louedec, Félicien; Thomas, Fabienne; Teixeira, Marcus; Flippot, Ronan; Mourey, Loic; Albiges, Laurence; Pudlarz, Thomas; Joly, Charlotte; Tournigand, Christophe; Chauvin, Jonathan; Puszkiel, Alicja; Chatelut, Etienne; Decleves, Xavier; Vidal, Michel; Goldwasser, François; Oudard, Stéphane; Medioni, Jacques; Vano, Yann-Alexandre

Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma

纳武利尤单抗血浆浓度和清除率与肾细胞癌患者的总生存期相关

Maritaz, Christophe; Combarel, David; Dalban, Cécile; Blondel, Louis; Broutin, Sophie; Marabelle, Aurelien; Albiges, Laurence; Paci, Angelo

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms

EGFR突变型非小细胞肺癌患者出现CCDC6-RET融合和BRAF V600E突变作为旁路耐药机制的个体化治疗

Marinello, Arianna; Parisi, Claudia; Vasseur, Damien; Combarel, David; Bihoreau, Juliette; Lavaud, Pernelle; Ezzedine, Rémy; Zullo, Lodovica; Friboulet, Luc; Zalcman, Gerard; Italiano, Antoine; Besse, Benjamin; Aldea, Mihaela

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

ANV419治疗复发/难治性晚期实体瘤患者的I期首次人体剂量递增研究

Mathiot, Laurent; Combarel, David; Cagnat, Justin; Delahousse, Julia; Ouali, Kaissa; Marabelle, Aurelien; Loriot, Yohann; Ponce, Santiago; Champiat, Stephane; Broutin, Sophie; Danlos, Francois-Xavier

Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies

了解并克服FGFR2驱动型恶性肿瘤对选择性FGFR抑制剂的耐药性

Francesco Facchinetti ,Yohann Loriot ,Floriane Brayé ,Damien Vasseur ,Rastislav Bahleda ,Ludovic Bigot ,Rémy Barbé ,Catline Nobre ,David Combarel ,Stefan Michiels ,Antoine Italiano ,Cristina Smolenschi ,Lambros Tselikas ,Jean-Yves Scoazec ,Santiago Ponce-Aix ,Benjamin Besse ,Fabrice André ,Ken A Olaussen ,Antoine Hollebecque ,Luc Friboulet

Breast cancer survivors' opinion on personalizing endocrine therapy and developing informative tools

乳腺癌幸存者对个性化内分泌治疗和开发信息工具的看法

Rassy, Elie; Benvenuti, Chiara; Akla, Sarra; Di Meglio, Antonio; Martin, Elise; Havas, Julie; Rieutord, André; Combarel, David; Fasse, Léonor; Scotté, Florian; Guéroult Accolas, Laure; Jacob, Guillemette; Bergougnoux, Anne; Delaloge, Suzette; Vaz-Luis, Ines; Pistilli, Barbara

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

卡博替尼在接受常规治疗的转移性肾细胞癌患者中的暴露-反应关系

Blanchet, Benoit; Xu-Vuillard, Alexandre; Jouinot, Anne; Puisset, Florent; Combarel, David; Huillard, Olivier; Le Louedec, Félicien; Thomas, Fabienne; Teixeira, Marcus; Flippot, Ronan; Mourey, Loic; Albiges, Laurence; Pudlarz, Thomas; Joly, Charlotte; Tournigand, Christophe; Chauvin, Jonathan; Puszkiel, Alicja; Chatelut, Etienne; Decleves, Xavier; Vidal, Michel; Goldwasser, François; Oudard, Stéphane; Medioni, Jacques; Vano, Yann-Alexandre

Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

一项全国性儿科队列研究,旨在探讨异基因造血干细胞移植治疗黏多糖贮积症的移植失败发生率及危险因素。该研究由法语区骨髓移植和细胞治疗学会委托开展。

Danhardt, Laura; Wiedemann, Arnaud; Michel, Gerard; Dalle, Jean-Hugues; Rialland, Fanny; Renard, Cécile; Jubert, Charlotte; Maertens, Johan; Sirvent, Anne; Buchbinder, Nimrod; Devalck, Christine; Brichard, Bénédicte; Paillard, Catherine; Nguyen, Stephanie; Paci, Angelo; Combarel, David; Castelle, Martin; Pagliuca, Simona; Pochon, Cecile

Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer

FGFR驱动的尿路上皮癌对选择性FGFR抑制剂的耐药性

Francesco Facchinetti ,Antoine Hollebecque ,Floriane Braye ,Damien Vasseur ,Yoann Pradat ,Rastislav Bahleda ,Cédric Pobel ,Ludovic Bigot ,Olivier Déas ,Juan David Florez Arango ,Giorgia Guaitoli ,Hayato Mizuta ,David Combarel ,Lambros Tselikas ,Stefan Michiels ,Sergey I Nikolaev ,Jean-Yves Scoazec ,Santiago Ponce-Aix ,Benjamin Besse ,Ken A Olaussen ,Yohann Loriot ,Luc Friboulet

Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study

卡博替尼在转移性肾细胞癌患者中的药代动力学、疾病进展和毒性之间的关联:一项药代动力学/药效学研究的结果

Cerbone, L; Combarel, D; Geraud, A; Auclin, E; Foulon, S; Alves Costa Silva, C; Colomba, E; Carril, L; Derosa, L; Flippot, R; Mir, O; Khoudour, N; Blanchet, B; Escudier, B; Paci, A; Albiges, L